Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Review

Primary and secondary autoimmune neutropenia

Franco Capsoni1 email, Piercarlo Sarzi-Puttini2 and Alberto Zanella3

Rheumatology Unit, Istituto Ortopedico Galeazzi, University of Milan, Milan, Italy

Rheumatology Unit, Ospedale L Sacco, University of Milan, Milan, Italy

Hematology Unit, Ospedale Maggiore Policlinico, Fondazione IRCCS, University of Milan, Milan, Italy

author email corresponding author email

Arthritis Research & Therapy 2005, 7:208-214doi:10.1186/ar1803

Published: 31 August 2005

Abstract

Antineutrophil antibodies are well recognized causes of neutropenia, producing both quantitative and qualitative defects in neutrophils and increased risk for infection. In primary autoimmune neutropenia (AIN) of infancy, a moderate to severe neutropenia is the sole abnormality; it is rarely associated with serious infections and exhibits a self-limited course. Chronic idiopathic neutropenia of adults is characterized by occurrence in late childhood or adulthood, greater prevalence among females than among males, and rare spontaneous remission. Secondary AIN is more commonly seen in adults and underlying causes include collagen disorders, drugs, viruses and lymphoproliferative disorders. In most patients with AIN, antibodies recognize antigens located on the IgG Fc receptor type 3b but other target antigens have been recently identified in secondary AIN. Granulocyte colony-stimulating factor is a proven treatment in patients with AIN of all types and is now preferred to other possible therapies.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.